NPCE Company Profile and Key Details

Q: Who are the executives of NPCE?

Dr. Martha J. MorrellChief Medical OfficerMr. Joel D. BeckerChief Executive Officer & DirectorMs. Kelley NicholasVice President of SalesMr. Andre G. MarquetteChief Commercial OfficerMs. Chi NguyenVice President of MarketingMs. Rebecca L. KuhnChief Financial Officer, Vice President of Fin. & Admin. and Assistant Sec.Mr. Michael L. FavetPres, Chief Executive Officer & DirectorMs. Irene ThomasVice President of HRMs. Irina RidleyChief Legal Officer & Corporation Sec.

NASDAQ : NPCE

NeuroPace

$14.04

0.17+1.23%

Open: 4:00 PM

56.04

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

NeuroPace, Inc. (NPCE) stock surged +1.23%, trading at $14.04 on NASDAQ, up from the previous close of $13.87. The stock opened at $14.04, fluctuating between $13.82 and $14.13 in the recent session.

Stock Snapshot

13.87

Prev. Close

478.68M

Market Cap

13.815

Day Low

-24.63

P/E Ratio

-0.57

EPS (TTM)

-0.74

Cash Flow per Share

14.04

Open

34.09M

Number of Shares

14.13

Day High

68.06%

Free Float in %

0.77

Book Value

107.48K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 11, 2026	14.04	14.13	13.82	14.04	107.48K
Sep 10, 2026	14.46	14.47	13.83	13.87	73.02K
Sep 09, 2026	14.68	14.77	14.41	14.50	78.58K
Sep 08, 2026	14.65	15.10	14.54	14.76	104.97K
Sep 04, 2026	14.62	14.90	14.47	14.90	92.32K
Sep 03, 2026	15.25	15.48	14.49	14.75	141.5K
Sep 02, 2026	14.75	15.56	14.68	15.19	163.71K
Sep 01, 2026	14.70	14.86	14.52	14.74	132.8K
Aug 31, 2026	14.41	14.67	14.24	14.65	148.26K
Aug 28, 2026	14.09	14.55	13.76	14.41	129.42K
Aug 27, 2026	14.60	14.81	14.07	14.13	148.09K
Aug 26, 2026	14.23	14.86	14.10	14.68	172.84K
Aug 25, 2026	14.04	14.27	13.97	14.16	153.4K
Aug 24, 2026	14.10	14.48	13.96	13.99	117.66K
Aug 21, 2026	14.14	14.22	13.87	14.03	115.98K
Aug 20, 2026	14.35	14.60	13.56	14.02	191.75K
Aug 19, 2026	14.45	15.28	14.45	14.64	106.59K
Aug 18, 2026	14.27	14.65	14.03	14.47	140.56K
Aug 17, 2026	14.58	14.68	14.18	14.28	197.41K
Aug 14, 2026	14.46	14.80	14.29	14.77	154.96K

Contact Details

Mountain View, CA 94043

United States

https://www.neuropace.com 650 237 2700

About Company

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Stock Peers

BRKRP

4.43+1.12%

Bruker Corporation$399.57 SWAV

-0.08-0.02%

ShockWave Medical, Inc.$334.75 UFPT

0.49+0.18%

UFP Technologies, Inc.$277.89 MASI

Masimo Corporation$179.95 ALGN

0.1+0.07%

Align Technology, Inc.$150.82 PODD

-2.72-2.02%

Insulet Corp.$131.96 IRTC

-1.45-1.28%

iRhythm Technologies, Inc.$111.43 DXCM

-1.48-1.75%

DexCom, Inc.$83.03 IRMD

0.35+0.43%

IRadimed Corporation$82.22 TMDX

-2.86-3.36%

TransMedics Group, Inc.$82.18

Frequently Asked Questions

What is the current NeuroPace, Inc. (NPCE) stock price?

NeuroPace, Inc. (NASDAQ: NPCE) stock price is $14.04 in the last trading session. During the trading session, NPCE stock reached the peak price of $14.13 while $13.82 was the lowest point it dropped to. The percentage change in NPCE stock occurred in the recent session was 1.23% while the dollar amount for the price change in NPCE stock was $0.17.

NPCE's industry and sector of operation?

The NASDAQ listed NPCE is part of Medical - Devices industry that operates in the broader Healthcare sector. NeuroPace, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of NPCE?

Dr. Martha J. Morrell
Chief Medical Officer
Mr. Joel D. Becker
Chief Executive Officer & Director
Ms. Kelley Nicholas
Vice President of Sales
Mr. Andre G. Marquette
Chief Commercial Officer
Ms. Chi Nguyen
Vice President of Marketing
Ms. Rebecca L. Kuhn
Chief Financial Officer, Vice President of Fin. & Admin. and Assistant Sec.
Mr. Michael L. Favet
Pres, Chief Executive Officer & Director
Ms. Irene Thomas
Vice President of HR
Ms. Irina Ridley
Chief Legal Officer & Corporation Sec.

How NPCE did perform over past 52-week?

NPCE's closing price is 52.28% higher than its 52-week low of $9.22 where as its distance from 52-week high of $19.60 is -28.37%.

How many employees does NPCE have?

Number of NPCE employees currently stands at 220.

Link for NPCE official website?

Official Website of NPCE is: https://www.neuropace.com

How do I contact NPCE?

NPCE could be contacted at phone 650 237 2700 and can also be accessed through its website. NPCE operates from 455 North Bernardo Avenue, Mountain View, CA 94043, United States.

How many shares of NPCE are traded daily?

NPCE stock volume for the day was 107.48K shares. The average number of NPCE shares traded daily for last 3 months was 188.13K.

What is the market cap of NPCE currently?

The market value of NPCE currently stands at $478.68M with its latest stock price at $14.04 and 34.09M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	220
Beta	1.95
Sales or Revenue	$65.42M
5Y Sales Change%	0.631%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Devices

Employees	220
Beta	1.95
Sales or Revenue	$65.42M
5Y Sales Change%	0.631%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Devices

NPCE Company Profile and Key Details

NeuroPace

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Company Overview

Technical Performance

Earnings & Analyst Outlook

Key Takeaways

Price Forecast & Outlook

Valuation Metrics